Mayo Clinic selected nference as its Clinical Data Analytics Platform partner to accelerate drug discovery and development across the biopharmaceutical ecosystem. nference will focus on identifying targets and biomarkers for new drugs, optimal matching of patients with therapeutic regimen, and real world data and real world evidence applications, such as label expansion, post-marketing surveillance and drug purposing.

nference

Cambridge

nference startup from Cambridge, United States is ranked 935 out of 2449 worldwide and 345 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map